featured
Comparison of Drug Discontinuation, Effectiveness, and Safety Between Clinical Trial–Eligible and –Ineligible Patients
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
JAMA Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Comparison of Drug Discontinuation, Effectiveness, and Safety Between Clinical Trial Eligible and Ineligible Patients in BADBIR
JAMA Dermatol 2018 Mar 28;[EPub Ahead of Print], KJ Mason, JNWN Barker, CH Smith, PJ Hampton, M Lunt, K McElhone, RB Warren, ZZN Yiu, CEM Griffiths, AD Burden,From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.